4.7 Article

Mu-opioid receptor selective superagonists produce prolonged respiratory depression

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats

Sara E. Walton et al.

Summary: This study aimed to investigate the pharmacokinetics of isotonitazene in rats and relate pharmacokinetic parameters to pharmacodynamic effects. The results showed that plasma concentrations of isotonitazene were positively correlated with the dose, and the half-life ranged from 23.4 to 63.3 minutes. The pharmacodynamic effects of isotonitazene were significantly correlated with plasma concentrations. Isotonitazene is a potent mu-opioid receptor agonist and poses substantial risk to users.

PSYCHOPHARMACOLOGY (2023)

Review Pharmacology & Pharmacy

Community guidelines for GPCR ligand bias: IUPHAR review 32

Peter Kolb et al.

Summary: GPCRs regulate various physiological processes and their effects depend on the pairing of a receptor and a ligand. Ligands that induce biased signalling can lead to better drug effects and fewer side effects. However, ligand bias is complex, making it necessary to develop guidelines for designing and reporting biased signalling experiments.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Chemistry, Analytical

A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography-Tandem Quadrupole Mass Spectrometry (LC-QQQ-MS)

Sara E. Walton et al.

Summary: Novel psychoactive substances (NPS) remain a threat to public health and safety, with the emergence of 2-benzylbenzimidazole analogs dominating the new synthetic opioid subclass. A liquid chromatography-tandem quadrupole mass spectrometry method was developed for the quantification of these drugs in human samples. The presence of isotonitazene and its metabolites were confirmed in various matrices, along with other nitazene analogs.

JOURNAL OF ANALYTICAL TOXICOLOGY (2022)

Article Physiology

Contribution of the caudal medullary raphe to opioid induced respiratory depression

Barbara Palkovic et al.

Summary: The study found that opioid-induced respiratory depression is the result of a combined effect on the respiratory rhythm generator and respiratory drive, with a complex role in the caudal medullary raphe possibly involving local antagonism of endogenous opioid receptor activation.

RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2022)

Article Toxicology

Identification of a novel opioid, N-piperidinyl etonitazene (etonitazepipne), in patients with suspected opioid overdose

Diane P. Calello et al.

Summary: This study describes the detection of N-piperidinyl etonitazene in three patients with opioid overdose, a compound not previously reported in human exposure. The findings suggest an outbreak of a novel synthetic compound in the illicit drug supply. Public health toxicosurveillance should include routine testing of these emerging synthetic compounds.

CLINICAL TOXICOLOGY (2022)

Article Substance Abuse

Emerging Characteristics of Isotonitazene-Involved Overdose Deaths: A Case-Control Study

Chelsea L. Shover et al.

Summary: This study aimed to epidemiologically characterize deaths involving isotonitazene by conducting a case control study in Cook County, IL and Milwaukee County, WI. Results showed that fatalities involving isotonitazene typically involved a greater number of substances and were more likely to co-involve the designer benzodiazepine flualprazolam.

JOURNAL OF ADDICTION MEDICINE (2021)

Letter Psychiatry

Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic

Joseph Friedman et al.

Summary: This cohort study examines the emerging trends of overdose-related cardiac arrests in the US during the COVID-19 pandemic using a large national emergency medical services database.

JAMA PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of Nitazene 2-Benzylbenzimidazole Synthetic Opioids

Marthe M. Vandeputte et al.

Summary: Several 2-benzylbenzimidazole opioids, known as nitazenes, have emerged on the illicit market, with isotonitazene being the most frequently encountered member. These compounds, structurally unrelated to fentanyl, have high potency and efficacy, with some analogues even surpassing fentanyl. The unexpected very high potency of the N-desethylisotonitazene metabolite, exceeding that of isotonitazene itself, suggests potential significant in vivo consequences.

ACS CHEMICAL NEUROSCIENCE (2021)

Review Biochemistry & Molecular Biology

DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles

Istvan Ujvary et al.

Summary: Etonitazene and its derivatives, developed in the late 1950s by the Swiss pharmaceutical giant CIBA, are potent analgesics with morphine-like effects. Recently, unscheduled synthetic opioids have emerged on the illicit drug market, leading to fatalities. This class of compounds has inspired research and led to the emergence of new psychoactive substances, impacting chemical neuroscience.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Biology

β-arrestin 2 germline knockout does not attenuate opioid respiratory depression

Iris Bachmutsky et al.

Summary: Opioids are highly effective analgesics but can lead to respiratory depression and death when used excessively. The development of biased agonists that provide pain relief without affecting breathing has been a focus of research. However, a study examining beta-arrestin 2-deficient mice found no link between beta-arrestin 2 and opioid respiratory depression, suggesting that the mechanism behind biased agonists' attenuated effect on breathing remains unclear.
Article Anesthesiology

Dose-dependent Respiratory Depression by Remifentanil in the Rabbit Parabrachial Nucleus/Kolliker-Fuse Complex and Pre-Botzinger Complex

Barbara Palkovic et al.

Summary: This study demonstrated that opioid reversal in the parabrachial nucleus/Kolliker-Fuse complex plus pre-Botzinger complex only partially reversed respiratory depression from analgesic doses, and even less from apneic opioid doses. The lack of recovery points to opioid-induced depression of respiratory drive that determines the activity of these areas.

ANESTHESIOLOGY (2021)

Article Neurosciences

Pharmacological and genetic manipulations at the μ-opioid receptor reveal arrestin-3 engagement limits analgesic tolerance and does not exacerbate respiratory depression in mice

Li He et al.

Summary: Opioid drugs act by activating the mu-opioid receptor to provide analgesic effects, while potentially leading to side effects such as respiratory depression and tolerance development. Recent studies challenge the prevailing hypothesis that arrestin-3 recruitment contributes to respiratory depression and analgesic tolerance, proposing that future development of safer opioids should target ligands that recruit both G protein and arrestin-3.

NEUROPSYCHOPHARMACOLOGY (2021)

Review Neurosciences

Toward Directing Opioid Receptor Signaling to Refine Opioid Therapeutics

Travis W. Grim et al.

BIOLOGICAL PSYCHIATRY (2020)

Article Pharmacology & Pharmacy

Morphine-induced respiratory depression is independent of β-arrestin2 signalling

Andrea Kliewer et al.

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Article Chemistry, Analytical

Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework

Alex J. Krotulski et al.

JOURNAL OF ANALYTICAL TOXICOLOGY (2020)

Article Biochemistry & Molecular Biology

Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists

Alexander Gillis et al.

SCIENCE SIGNALING (2020)

Article Biochemistry & Molecular Biology

TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome

Reid H. J. Olsen et al.

NATURE CHEMICAL BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Biased versus Partial Agonism in the Search for Safer Opioid Analgesics

Joaquim Azevedo Neto et al.

MOLECULES (2020)

Review Pharmacology & Pharmacy

Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor

Alexander Gillis et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2020)

Article Multidisciplinary Sciences

An inactive receptor-G protein complex maintains the dynamic range of agonist-induced signaling

Wonjo Jang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Physiology

The contribution of endogenous glutamatergic input in the ventral respiratory column to respiratory rhythm

Denise R. Cook-Snyder et al.

RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2019)

Letter Medicine, General & Internal

Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016

Christopher M. Jones et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Review Pharmacology & Pharmacy

Allostery at opioid receptors: modulation with small molecule ligands

Kathryn E. Livingston et al.

BRITISH JOURNAL OF PHARMACOLOGY (2018)

Article Multidisciplinary Sciences

Dynamic and Kinetic Elements of μ-Opioid Receptor Functional Selectivity

Abhijeet Kapoor et al.

SCIENTIFIC REPORTS (2017)

Review Pharmacology & Pharmacy

Superagonism at G protein-coupled receptors and beyond

R. Schrage et al.

BRITISH JOURNAL OF PHARMACOLOGY (2016)

Article Multidisciplinary Sciences

Structure-based discovery of opioid analgesics with reduced side effects

Aashish Manglik et al.

NATURE (2016)

Article Behavioral Sciences

Delta opioid receptors expressed in forebrain GABAergic neurons are responsible for SNC80-induced seizures

Paul Chu Sin Chung et al.

BEHAVIOURAL BRAIN RESEARCH (2015)

Article Biochemistry & Molecular Biology

PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome

Wesley K. Kroeze et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)

Article Biochemistry & Molecular Biology

PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome

Wesley K. Kroeze et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)

Article Pharmacology & Pharmacy

A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphines

Scott M. DeWire et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)

Article Biochemistry & Molecular Biology

A Simple Method for Quantifying Functional Selectivity and Agonist Bias

Terry Kenakin et al.

ACS CHEMICAL NEUROSCIENCE (2012)

Article Neurosciences

Mu-Opioid Receptor Coupling to Gαo Plays an Important Role in Opioid Antinociception

Jennifer T. Lamberts et al.

NEUROPSYCHOPHARMACOLOGY (2011)

Article Pharmacology & Pharmacy

Estimation of agonist activity at G protein-coupled receptors:: Analysis of M2 muscarinic receptor signaling through Gi/o, Gs, and G15

Michael T. Griffin et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)

Article Pharmacology & Pharmacy

Analysis of allosterism in functional assays

FJ Ehlert

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)

Article Pharmacology & Pharmacy

Morphine side effects in beta-arrestin 2 knockout mice

KM Raehal et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)